Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.46 -2.00 (-2.65%)
As of: Oct 2, 2026 · 3:44 PM EDT

Tarsus Pharmaceuticals (TARS) Return on Assets [ROA] (2020 - 2026)

Updated

Tarsus Pharmaceuticals' Return on Assets [ROA] was -7.87% in Q2 2026, up 10.57 percentage points from -18.44% a year earlier and up 0.18 percentage points from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Tarsus Pharmaceuticals came in at -14.14%, up 21.83 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +9.14 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -35.97% in FY2024 (+19.12 pp), -55.09% in FY2023 (-24.56 pp), -30.53% in FY2022 (-22.65 pp) and -7.88% in FY2021 (+15.40 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q4 2021.
  • Compared with a year earlier, Return on Assets [ROA] has increased for nine straight quarters, with an average year-over-year change of +17.96 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2025 (a gain of 24.82 percentage points); the worst was Q4 2023 (a drop of 24.57 percentage points).
  • Per Business Quant data, TARS's Return on Assets [ROA] in the three quarters before Q2 2026 was -8.05% (Q1 2026), -11.70% (Q4 2025) and -15.74% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn -7.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.87%
Mar 31, 2026 -8.05%
Dec 31, 2025 -11.70%
Sep 30, 2025 -15.74%
Jun 30, 2025 -18.44%
Mar 31, 2025 -23.44%
Dec 31, 2024 -30.11%
Sep 30, 2024 -35.26%
Jun 30, 2024 -40.83%
Mar 31, 2024 -48.27%
Dec 31, 2023 -51.02%
Sep 30, 2023 -46.95%
Jun 30, 2023 -45.41%
Mar 31, 2023 -29.57%
Dec 31, 2022 -26.45%
Sep 30, 2022 -25.46%
Jun 30, 2022 -25.40%
Mar 31, 2022 -23.55%
Dec 31, 2021 -6.61%
Sep 30, 2021 -4.66%
API Access

Tarsus Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TARS&period=max&api_key=YOUR_API_KEY